USP 797 covers sterile compounding, which includes injectable medications like semaglutide
The protocol was approved by local institutional review boards and the trial complied with the International Conference on Harmonization Good Clinical Practice guidelines and the Declaration of Helsinki
Updated February 2026 GLP-1 Drug Comparison Tool: Compare Weight Loss Drugs Side by Side Interactive comparison tool for GLP-1 weight loss drugs
Aneta Sokal-Dembowska, Ewelina Polak-Szczybyo, Kacper Helma, Patrycja Musz, Maciej Setlik, Weronika Fic, Dawid Wachowiak, Sara Jarmakiewicz-Czaja Current Issues in Molecular Biology .2025
Weight loss up to 29% at 68 weeks and knee pain reduction in osteoarthritis are under investigation
This led to clinical trials specifically for obesity, and several are now FDA-approved for weight management